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Background: The prevalence of coronary artery disease (CAD)
in end stage liver disease (ESLD) being evaluated for orthotopic
liver transplantation (OLT) is unclear based on variable deﬁnition
used for CAD.
Aim: The objective of this study to investigate the prevalence of
abnormal stress myocardial perfusion SPECT (MPS) imaging, as a
marker for CAD, among patients with ESLD who were referred
for stress MPS imaging as a routine work up before OLT.
Methods and materials: We reviewed data on 167 patients who
were referred for MPS as a routine work up before OLT over last
2 years. All patients underwent evaluation for CAD risk factors
(age, hypercholesterolemia, diabetes mellitus, hypertension, and
smoking), and stress MPS per standard protocol.
Results: The total number patients referred for stress MPS was
167 patients. 7 patients (4%) were excluded for being have
nondiagnostic studies. 147 patients (92%) have normal but only
13 patients (8%) have abnormal MPS scans. Diabetes mellitus
and male gender were the most independent risk factors for abnor-
mal MPS with p-value of .046, and 0.26 respectively. There was no
signiﬁcant association between the abnormal result with hyperten-
sion, hypercholesterolemia, smoking, age or etiology of the liver
disease.
Conclusions: Based on our data the prevalence of abnormal
MPS and LVEF in patients with ESLD is 8%. DM and male gen-
der were the most independent predictor factors for abnormal
MPS. True prevalence of CAD and usefulness of MPS in patients
with ESLD can only be studied using a very large and randomized
prospective study.
doi:10.1016/j.jsha.2011.02.056
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Introduction: The prevalence and the outcomes of congestive
heart failure in Saudi populations hospitalized with acute coro-
nary syndrome (ACS) are not well known. The aim of this study
was to assess prevalence, clinical features, and outcomes of con-
gestive heart failure (CHF) in Saudi populations admitted with
acute coronary syndrome.
Methods and study population: The data was prospectively col-
lected on all patients hospitalized with acute coronary syndrome
between December 2005 and December 2007. The patients were
divided into two groups. First group included patients who pre-
sented with ACS and also were found to have CHF. Second group
included patients who presented with ACS but did not have CHF.
Patients’ characteristics and hospitalization data were collected
and compared between the two groups. Primary outcomes in-
cluded cardiogenic shock, Stroke, death and the composite end
point of these three outcomes.
Results: Out of 4559 patients identiﬁed, 940 (20%) had CHF;
the mean age of this group was higher compared to non-CHF
group (58.7 vs 54.3; P= 0.0001). CHF group included less males
(70% vs 79%; P= 0.0001) and patients were more likely to have
diabetes (72% vs 54%; P= 0.0001), hypertension (64% vs 54%;
P= 0.0001), history of CVA or TIA (9.5% vs 5.5%; P=
0.0001). Higher percentage of those patients also received previous
revascularization including PCI (17% vs 14%; P= 0.0001) or
CABG (9% vs 5%; P= 0.0001). On presentation, NSTEMI
was more common in CHF group (47% vs 35%; P= 0.0001)
and the patients were more likely to be hypotensive, tachycardic
and have higher initial troponin levels (72% vs 62%;
P= 0.0001). The overall in hospital adverse outcomes of patient
with ACS and CHF were found to be higher than those with
ACS without CHF. Mortality and cardiogenic shock were signif-
icantly higher in the former group (4.7% vs 2.7%; P= 0.002) and
(12% vs 2.5%; P= 0.0001) respectively. In regards to the in hos-
pital treatment of patients with ACS and heart failure compared
to non CHF, patients with CHF were less likely to receive B-
blockers (74% vs 87%; P= 0.0001), ACEI (68% vs 70%;
P= 0.0001) Statins (94% vs 96%; P= 0.003) and PCI (22% vs
37%; P= 0.0001).
Conclusion: We concluded that patients hospitalized with ACS
and CHF are older, more likely to be diabetic and hypertensive
and more likely to present with NSTEMI and be hemodynami-
cally unstable than the non HF group. This may explain the higher
incidence of adverse in-hospital outcomes in this group of patients
including cardiogenic shock, mortality and composite end point of
cardiogenic shock, mortality, stroke and death.
doi:10.1016/j.jsha.2011.02.057
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Objective: Demonstrating the effect of blood-let out cupping in
acute myocardial conditions.
Subjective: The rising challenge of cardiovascular disease con-
stitutes an actual burden (Shimokawa and Yasuda, 2008; White
and Chew, 2008; Darius et al., 2008). The real clue in ischemic car-
diac conditions is to prevent progression into critical ischemia
than treatment of complications. The accumulation of toxic
metabolites and inﬂammatory mediators in the body is a fact that
has been reported in literature. These substances can induce vascu-
lar spasm and other effects on vascular endothelium (Ozben and
Erdogan, 2008). Impairment of the vascular endothelial function
is involved in the pathogenesis of wide variety of cardiovascular
diseases and hence is considered a therapeutic target (Shimokawa
and Yasuda, 2008). Production of ischemic metabolites within the
myocardium due to lack of proper perfusion constitutes a source
of toxic elements which can contribute to progression of the coro-
nary heart disease (Newton et al., 2008). Elimination of these toxic
elements is a challenge that would deﬁnitely help to correct an
underling circulatory error.
Key of study: Withdrawal of the ischemic tissue metabolites,
being interstitial, is only feasible via suction by the traditional
therapeutic cups; a maneuver which could lead to correction of
an associated ischemic situation.
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